Congestive Cardiomyopathy in Infants and Children: Incidence, Diagnosis, and Follow-up

1986 ◽  
pp. 1175-1179
Author(s):  
J. Areias ◽  
I. Valente ◽  
A. Duarte ◽  
J. Maciel ◽  
D. Cunha
PEDIATRICS ◽  
1996 ◽  
Vol 97 (4) ◽  
pp. 443-448
Author(s):  
Alan N. Langnas ◽  
B. W. Shaw ◽  
Dean L. Antonson ◽  
Stuart S. Kaufman ◽  
David R. Mack ◽  
...  

Objective. This report discusses the preliminary experience with intestinal transplantation in children at the University of Nebraska Medical Center. Patients. During the past 4 years, 16 intestinal transplants have been performed in infants and children. Thirteen have been combined liver and bowel transplants, and the remainder were isolated intestinal transplants. Nearly half of the patients were younger than 1 year of age at the time of surgery, and the vast majority were younger than 5 years of age. All but one had short bowel syndrome. Results. The 1-year actuarial patient and graft survival rates for recipients of liver and small bowel transplants were 76% and 61%, respectively. Eight of 13 patients who received liver and small bowel transplants remain alive at the time of this writing, with a mean length of follow-up of 263 (range, 7 to 1223) days. Six patients are currently free of total parenteral nutrition. All three patients receiving isolated intestinal transplants are alive and free of parenteral nutrition. The mean length of follow-up is 384 (range, 330 to 450) days. Major complications have included severe infections and rejection. Lymphoproliferative disease, graft-versus-host disease, and chylous ascites have not been major problems. Conclusions. Although intestinal transplantation is in its infancy, these preliminary results suggest combined liver and bowel transplants and isolated intestinal transplantation may be viable options for some patients with intestinal failure caused by short bowel syndrome or other gastrointestinal disease in whom long-term total parenteral nutrition is not an attractive option.


Radiology ◽  
1985 ◽  
Vol 154 (3) ◽  
pp. 677-682 ◽  
Author(s):  
Y Y Lee ◽  
J P Glass ◽  
J van Eys ◽  
S Wallace

2013 ◽  
Vol 24 (2) ◽  
pp. 268-274 ◽  
Author(s):  
Massimo A. Padalino ◽  
Elena Reffo ◽  
Alessia Cerutti ◽  
Valentina Favero ◽  
Roberta Biffanti ◽  
...  

AbstractPrimary cardiac tumours in infants and children are extremely rare, with an estimated incidence of 0.2% according to echocardiographic studies. Owing to their rarity, there is very little literature available, and most knowledge is based on collections of case reports. Therefore, we reviewed retrospectively our 27 years of clinical experience on the overall management of cardiac tumours among children in order to improve not only our knowledge but also to provide others with information about the incidence, clinical presentation, management, and long-term outcome of this rare disease. Between April, 1982 and April, 2009, 52 children were diagnosed with cardiac tumours at our Institution. Medical records and follow-up echocardiographic evaluations were studied. The diagnosis was prenatal in 35% of the patients. The most frequent tumour types were rhabdomyomas (61.5%), fibromas (15.4%), and myxomas (5.8%). There were no cases of primary malignant tumours. All diagnoses were achieved using two-dimensional echocardiography, and for 12 patients a pathological analysis was carried out. A total of 41 patients (79%) were managed medically, whereas 11 (21%) patients underwent surgical treatment. At a mean follow-up of 7.2 ± 5.4 years, two patients died of complications related to cardiac transplantation; all the remaining patients are in excellent clinical condition. In conclusion, cardiac tumours in paediatric practice are usually clinically and histologically benign. Only a few cases need surgery. Up to one-third of the cardiac masses are detectable prenatally. Rhabdomyoma is the most common histotype, followed by fibroma and myxoma. The long-term prognosis is generally good.


2020 ◽  
Vol 49 (4) ◽  
pp. 267-277
Author(s):  
Lisa F. Clark

Ready to Use Therapeutic Foods (RUTFs) are used in international food assistance strategies as a safe and effective way of treating children suffering from severe acute malnutrition (SAM). Though the peanut-based formulation has a proven track record in terms of efficacy in treating SAM around the world, the conventional formulation is not without challenges. Concerns regarding cost, the availability of local ingredients, the presence of aflatoxin, shifting global supply patterns, and dietary appropriateness of the peanut-based RUTF have encouraged researchers to experiment with other lipid sources in formulations. This shift requires not only changes to RUTF formulations, but also changes to supply chain activities. The goal of this review is to first, provide an update on the efficacy of recently trialed non-peanut RUTF formulations in treating SAM in infants and children and second, to review recent UN agency led interventions into local/regional RUTF supply chains and programmatic capacity. Based on published documents (2017–2019), this review flags three significant issues requiring further attention from the international food assistance community: the need for follow-up studies of children treated for SAM with RUTFs in programmatic countries, a regional customization of Community-Based Management of Acute Malnutrition (CMAM) protocols to maximize cost effectiveness and programmatic coverage, and an increase in the number of studies focusing on the acceptability of non-peanut RUTF formulations by the infants and children in low and medium income countries.


2007 ◽  
Vol 31 (11) ◽  
pp. 2255-2259 ◽  
Author(s):  
Ulf Abdel-Rahman ◽  
Andreas Simon ◽  
Peter Ahrens ◽  
Klaus Heller ◽  
Anton Moritz ◽  
...  

1988 ◽  
Vol 115 (6) ◽  
pp. 1263-1267 ◽  
Author(s):  
Kyung J Chung ◽  
David R Fulton ◽  
Richard Lapp ◽  
Stephen Spector ◽  
David J Sahn

Sign in / Sign up

Export Citation Format

Share Document